🔎 Trials Near Me

Beranda › Kanker Prostat › California › Stockton

Uji klinis Kanker Prostat di Stockton, CA

6 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Stockton (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Saint Joseph's Medical Center, Stockton
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Menerima pesertaFase 3
  • Kaiser Permanente-Stockton, Stockton
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05946213

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Menerima pesertaFase 3
  • Saint Joseph's Medical Center, Stockton
Usia 18 ke atas · Pria · Diperbarui 19 Agu 2026 · NCT04423211

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Menerima pesertaFase 3
  • Saint Joseph's Medical Center, Stockton
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT06592924

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

Menerima pesertaFase 3
  • Kaiser Permanente-Stockton, Stockton
Usia 18 ke atas · Pria · Diperbarui 14 Apr 2026 · NCT06235697

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Menerima pesertaFase 3
  • Kaiser Permanente-Stockton, Stockton
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2025 · NCT03678025

Uji klinis Kanker Prostat di kota lain

Studi lain di Stockton

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.